The historic rise of Viagra has firmly established as a benchmark of pharmaceutical success, yet its position within the broader market now triggers questions about future yields . Generic versions are eroding market share, causing concerns that supporting companies closely tied to Viagra's once-dominant influence could be a dangerous move , especi